Current Urology Reports

, Volume 3, Issue 5, pp 388–395 | Cite as

Surgical management of overactive bladder

  • Michael Gross
  • Timothy B. Boone
  • Rodney A. Appell
Article

Abstract

The majority of patients with overactive bladder (OAB) can be managed with office-based techniques. When medical therapy fails as treatment for OAB, surgical intervention ranging from electric stimulation administered in the office to extensive procedures, such as augmentation or urinary diversion, may be needed. Any surgical intervention should be tailored to the patient with consideration of the degree of his or her discomfort, underlying pathology, general health, and obviously, the patient’s own motivation.

Keywords

Overactive Bladder Urge Incontinence Interstitial Cystitis Urinary Diversion Pudendal Nerve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Hanno PM, Wein AJ: Interstitial cystitis. J Urol 1987, 138:595–596.PubMedGoogle Scholar
  2. 2.
    Hanno PM, Wein AJ: Conservative therapy of interstitial cystitis. Semin Urol 1991, 9:143–147.PubMedGoogle Scholar
  3. 3.
    Rofeim O, Shupp-Byrne D, Mulholland GS, et al.: The effects of hydrodistention on bladder surface mucin. Urology 2001, 57:130–132.PubMedCrossRefGoogle Scholar
  4. 4.
    Chai TC, Zhang CO, Shoenfelt JL, et al.: Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis. J Urol 2000, 163:1440–1444. This article may finally explain the reason why hydrodistention appears to be useful in the management of IC.PubMedCrossRefGoogle Scholar
  5. 5.
    Ingelman-Sundberg A: Partial denervation of the bladder. A new operation for the treatment of urge incontinence and similar conditions in women. Acta Obstet Gynecol Scand 1959, 38:487–490.PubMedCrossRefGoogle Scholar
  6. 6.
    Cespedes RD, Cross CA, McGuire EJ: Modified Ingelman-Sundberg bladder denervation procedure for intractable urge incontinence. J Urol 1996, 156:1744–1747.PubMedCrossRefGoogle Scholar
  7. 7.
    Susset JG, Pinheiro J, Otton P, et al.: Selective phenolization and neurotomy in the treatment of neurogenic bladder dysfunction due to an incomplete central lesion [in French]. J Urol Nephrol (Paris) 1969, 75(Suppl 12):502–504.Google Scholar
  8. 8.
    Blackford HN, Murray K, Stephenson TP, et al.: Results of transvesical infiltration of the pelvic plexuses with phenol in 116 patients. Br J Urol 1984, 56:647–649.PubMedGoogle Scholar
  9. 9.
    Harris RG, Constantinou CE, Stamey TA: Extravesical subtrigonal injection of 50 per cent ethanol for detrusor instability. J Urol 1988, 140:111–116.PubMedGoogle Scholar
  10. 10.
    Ramsay IN, Clancy S, Hilton P: Subtrigonal phenol injections in the treatment of idiopathic detrusor instability in the female: a long-term urodynamic follow-up. Br J Urol 1992, 69:363–365.PubMedGoogle Scholar
  11. 11.
    McInerney PD, Vanner TF, Matenhelia S, et al.: Assessment of the long-term results of subtrigonal phenolization. Br J Urol 1991, 67:586–587.PubMedGoogle Scholar
  12. 12.
    Madjar S, Smith D, Balzarro M, Appell RA: Bupivacaine injections prior to subtrigonal phenolization: preliminary results [abstract]. J Urol 2001, 65(Suppl):277.Google Scholar
  13. 13.
    Bennani S: Evaluation of sub-trigonal injections in the treatment of the hyperactive bladder [in French]. Ann Urol 1994, 28:13–19.Google Scholar
  14. 14.
    Worth PH: The treatment of interstitial cystitis by cystolysis with observations on cystoplasty. A review after 7 years. Br J Urol 1980, 52:232–235.PubMedGoogle Scholar
  15. 15.
    Freiha FS, Stamey TA: Cystolysis: a procedure for the selective denervation of the bladder. J Urol 1980, 123:360–363.PubMedGoogle Scholar
  16. 16.
    Caldwell K: The electrical control of sphincter incompetence. Lancet 1963, 2:174–175.PubMedCrossRefGoogle Scholar
  17. 17.
    Vodusek DB, Light JK, Libby JM: Detrusor inhibition induced by stimulation of pudendal nerve afferents. Neurourol Urodyn 1986, 5:381–384.CrossRefGoogle Scholar
  18. 18.
    Zvara P, Sahi S, Hassouna MM: An animal model for the neuromodulation of neurogenic bladder dysfunction. Br J Urol 1998, 82:267–271.PubMedGoogle Scholar
  19. 19.
    Fall M, Lindstrom S: Electrical stimulation. A physiologic approach to the treatment of urinary incontinence. Urol Clin North Am 1991, 18:393–407.PubMedGoogle Scholar
  20. 20.
    McGuire EJ, Zhang SC, Horwinski ER, et al.: Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol 1983, 129:78–79.PubMedGoogle Scholar
  21. 21.
    Klingler HC, Pycha A, Schmidbauer J, et al.: Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology 2000, 56:766–771.PubMedCrossRefGoogle Scholar
  22. 22.
    Govier FE, Litwiller S, Nitti V, et al.: Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol 2001, 165:1193–1198. This interesting paper demonstrates the utility of the SANS device as a minimally invasive ambulatory technique for the control of bladder hyperactivity.PubMedCrossRefGoogle Scholar
  23. 23.
    Juenemann KP, Lue TF, Schmidt RA, et al.: Clinical significance of sacral and pudendal nerve anatomy. J Urol 1988, 139:74–80.PubMedGoogle Scholar
  24. 24.
    Koldewijn EL, Rosier PF, Meuleman EJ, et al.: Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients. J Urol 1994, 152:2071–2075.PubMedGoogle Scholar
  25. 25.
    Janknegt RA, Hassouna MM, Siegel SW, et al.: Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur Urol 2001, 39:101–106. This is a very important paper discussing the expected outcomes of sacral neuromodulation in patients with refractory UI.PubMedCrossRefGoogle Scholar
  26. 26.
    Cartwright PC, Snow BW: Bladder autoaugmentation: early clinical experience. J Urol 1989, 142:505–508.PubMedGoogle Scholar
  27. 27.
    Swami KS, Feneley RC, Hammonds JC, et al.: Detrusor myectomy for detrusor overactivity: a minimum 1-year follow-up. Br J Urol 1998, 81:68–72.PubMedGoogle Scholar
  28. 28.
    Stohrer M, Goepel M, Kramer G, et al.: Detrusor myectomy (autoaugmentation) in the treatment of hyper-reflexive low compliance bladder [in German]. Urologe A 1999, 38:30–37.PubMedCrossRefGoogle Scholar
  29. 29.
    Siracusano S, Trombetta C, Liguori G, et al.: Laparoscopic bladder auto-augmentation in an incomplete traumatic spinal cord injury. Spinal Cord 2000, 38:59–61.PubMedCrossRefGoogle Scholar
  30. 30.
    Kennelly MJ, Gormley EA, McGuire EJ: Early clinical experience with adult bladder auto-augmentation. J Urol 1994, 152:303–306.PubMedGoogle Scholar
  31. 31.
    Leng WW, Blalock HJ, Fredriksson WH, et al.: Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation. J Urol 1999, 161:758–763. This report presents the best results attained with autoaugmentation and indicates that autoaugmentation should be attempted before involving other organ systems in the treatment of bladder hyperactivity.PubMedCrossRefGoogle Scholar
  32. 32.
    Goodwin WE, Winter CC: Results of ileocystoplasty. J Urol 1958, 80:461–466.PubMedGoogle Scholar
  33. 33.
    Christmas TJ, Holmes SA, Hendry WF: Bladder replacement by ileocystoplasty: the final treatment for interstitial cystitis. Br J Urol 1996, 78:69–73.PubMedGoogle Scholar
  34. 34.
    Baskin LS, Tanagho EA: Pelvic pain without pelvic organs. J Urol 1992, 147:683–686.PubMedGoogle Scholar
  35. 35.
    Mundy AR, Stephenson TP: “Clam” ileocystoplasty for the treatment of refractory urge incontinence. Br J Urol 1985, 57:641–646.PubMedCrossRefGoogle Scholar
  36. 36.
    Goldwasser B, Webster GD: Augmentation and substitution enterocystoplasty. J Urol 1986, 135:215–224.PubMedGoogle Scholar
  37. 37.
    Awad SA, Al-Zahrani HM, Gajewski JB, et al.: Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol 1998, 81:569–573.PubMedGoogle Scholar
  38. 38.
    Flood HD, Malhotra SJ, O’Connell HE, et al.: Long-term results and complications using augmentation cystoplasty in reconstructive urology. Neurourol Urodyn 1995, 14:297–309.PubMedCrossRefGoogle Scholar
  39. 39.
    King L: Cystoplasty in children. In Bladder Reconstruction and Continent Urinary Diversion, edn 2. Edited by King SA, Webster GD. St. Louis: Mosby Year Book; 1991:115–125.Google Scholar
  40. 40.
    Wood GA, Heathcote PS, Nicol DL: Bowel motility after enterocystoplasty. Br J Urol 1998, 81:565–568.PubMedGoogle Scholar
  41. 41.
    Goldwasser B, Barrett DM, Webster GD, et al.: Cystometric properties of ileum and right colon after bladder augmentation, substitution or replacement. J Urol 1987, 138:1007–1008.PubMedGoogle Scholar
  42. 42.
    Koch MO, McDougal WS, Hall MC, et al.: Long-term metabolic effects of urinary diversion: a comparison of myelomeningocele patients managed by clean intermittent catheterization and urinary diversion. J Urol 1992, 147:1343–1347.PubMedGoogle Scholar
  43. 43.
    Filmer RB, Spencer JR: Malignancies in bladder augmentations and intestinal conduits. J Urol 1990, 143:671–678.PubMedGoogle Scholar
  44. 44.
    Gillon G, Mundy AR: The dissolution of urinary mucus after cystoplasty. Br J Urol 1989, 63:372–374.PubMedGoogle Scholar

Copyright information

© Current Science Inc 2002

Authors and Affiliations

  • Michael Gross
    • 1
  • Timothy B. Boone
    • 1
  • Rodney A. Appell
    • 1
  1. 1.Scott Department of UrologyBaylor College of MedicineHoustonUSA

Personalised recommendations